Nephrolithiasis as a risk factor for CKD: The atherosclerosis risk in communities study

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 11, 2015, Pages 2023-2029

  Kummer, Andrew E ^a   Grams, Morgan ^b   Lutsey, Pamela ^a   Chen, Yuan ^b   Matsushita, Kunihiro ^b   Köttgen, Anna ^b,c   Folsom, Aaron R ^a   Coresh, Josef ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALLOPURINOL; C REACTIVE PROTEIN; CREATININE; DIURETIC AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMMUNITY PROGRAM; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HUMAN; ICD-9-CM; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEPHELOMETRY; NEPHROLITHIASIS; PROSPECTIVE STUDY; RACE; SENSITIVITY ANALYSIS; TELEPHONE INTERVIEW; URINALYSIS; BLOOD; COMPLICATION; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR;

ATHEROSCLEROSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEPHROLITHIASIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; URIC ACID;

EID: 84946719784     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10111014     Document Type: Article

References (42)

1. Jungers P, Joly D, Barbey F, Choukroun G, Daudon M: ESRD caused by nephrolithiasis: Prevalence, mechanisms, and prevention. Am J Kidney Dis 44: 799-805, 2004
2. Evan AP, Lingeman JE, Worcester EM, Bledsoe SB, Sommer AJ, Williams JC Jr, Krambeck AE, Philips CL, Coe FL: Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease. Kidney Int 78: 310-317, 2010
3. Viers BR, Lieske JC, Vrtiska TJ, Herrera Hernandez LP, Vaughan LE, Mehta RA, Bergstralh EJ, Rule AD, Holmes DR, III, Krambeck AE: Endoscopic and histologic findings in a cohort of uric acid and calcium oxalate stone formers. Urology 85: 771-776, 2015
4. Evan AP, Willis LR, Connors B, Reed G, McAteer JA, Lingeman JE: Shock wave lithotripsy-induced renal injury. AmJ Kidney Dis 17: 445-450, 1991
5. Tibblin G: High blood pressure in men aged 50-a population study of men born in 1913. Acta Med Scand Suppl 470: 1-84, 1967
6. Robertson WG, Peacock M, Baker M, Marshall DH, Pearlman B, Speed R, Sergeant V, Smith A: Studies on the prevalence and epidemiology of urinary stone disease in men in Leeds. Br J Urol 55: 595-598, 1983
7. Cirillo M, Laurenzi M: Elevated blood pressure and positive history of kidney stones: Results from a population-based study. J Hypertens Suppl 6: S485-S486, 1988
8. Cappuccio FP, Strazzullo P, Mancini M: Kidney stones and hypertension: Population based study of an independent clinical association. BMJ 300: 1234-1236, 1990
9. Soucie JM, Coates RJ, McClellan W, Austin H, Thun M: Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epidemiol 143: 487-495, 1996
10. Madore F, Stampfer MJ, Rimm EB, Curhan GC: Nephrolithiasis and risk of hypertension. Am J Hypertens 11: 46-53, 1998
11. Rule AD, Roger VL, Melton LJ III, Bergstralh EJ, Li X, Peyser PA, Krambeck AE, Lieske JC: Kidney stones associate with increased risk for myocardial infarction. J AmSoc Nephrol 21: 1641-1644, 2010
12. Ferraro PM, Taylor EN, Eisner BH, Gambaro G, Rimm EB, Mukamal KJ, Curhan GC: History of kidney stones and the risk of coronary heart disease. JAMA 310: 408-415, 2013
13. Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Samuel S, Klarenbach SW, Curhan GC, Tonelli M; Alberta Kidney Disease Network: Kidney stones and cardiovascular events: A cohort study. Clin J Am Soc Nephrol 9: 506-512, 2014
14. Reiner AP, Kahn A, Eisner BH, Pletcher MJ, Sadetsky N, Williams OD, Polak JF, Jacobs DR Jr, Stoller ML: Kidney stones and subclinical atherosclerosis in young adults: The CARDIA study. JUrol 185: 920-925, 2011
15. Taylor EN, Stampfer MJ, Curhan GC: Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 68: 1230-1235, 2005
16. Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 365: 1415-1428, 2005
17. Cameron MA, Maalouf NM, Adams-Huet B, Moe OW, Sakhaee K: Urine composition in type 2 diabetes: Predisposition to uric acid nephrolithiasis. J Am Soc Nephrol 17: 1422-1428, 2006
18. Maalouf NM, Cameron MA, Moe OW, Adams-Huet B, Sakhaee K: Low urine pH: A novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2: 883-888, 2007
19. Lieske JC, de la Vega LS, Gettman MT, Slezak JM, Bergstralh EJ, Melton LJ 3rd, Leibson CL: Diabetes mellitus and the risk of urinary tract stones: A population-based case-control study. Am J Kidney Dis 48: 897-904, 2006
20. Vupputuri S, Soucie JM, McClellan W, Sandler DP: History of kidney stones as a possible risk factor for chronic kidney disease. Ann Epidemiol 14: 222-228, 2004
21. Gillen DL, Worcester EM, Coe FL: Decreased renal function among adults with a history of nephrolithiasis: A study of NHANES III. Kidney Int 67: 685-690, 2005
22. Rule AD, Bergstralh EJ, Melton LJ III, Li X, Weaver AL, Lieske JC: Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 4: 804-811, 2009
23. Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Morgan C, Samuel S, Klarenbach SW, Curhan GC, Tonelli M; Alberta Kidney Disease Network: Kidney stones and kidney function loss: A cohort study. BMJ 345: e5287, 2012
24. Statistics Canada: 2006 Community Profiles, Alberta. Available at: http://www12.statcan.gc.ca/census-recensement/2006/dp-pd/ prof/92-591/details/page.cfm?Lang=E&Geo1=PR&Code1= 48&Geo2=PR&Code2=01&Data=Count&SearchText= Alberta&SearchType=Begins&SearchPR=01&B1=All&Custom=. Accessed September 10, 2013
25. El-Zoghby ZM, Lieske JC, Foley RN, Bergstralh EJ, Li X, Melton LJ 3rd, Krambeck AE, Rule AD: Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol 7: 1409-1415, 2012
26. Shoag J, Halpern J, Goldfarb DS, Eisner BH: Risk of chronic and end stage kidney disease in patients with nephrolithiasis. J Urol 192: 1440-1445, 2014
27. Tarver-Carr ME, Powe NR, Eberhardt MS, LaVeist TA, Kington RS, Coresh J, Brancati FL: Excess risk of chronic kidney disease among African-American versus white subjects in the United States: A population-based study of potential explanatory factors. J Am Soc Nephrol 13: 2363-2370, 2002
28. Stankus N, Hammes M, Gillen D, Worcester E: African American ESRD patients have a high pre-dialysis prevalence of kidney stones compared to NHANES III. Urol Res 35: 83-87, 2007
29. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS: Uric acid and incident kidney disease in the community. J Am Soc Nephrol 19: 1204-1211, 2008
30. Obermayr RP, Temml C, Gutjahr G, Knechtelsdorfer M, Oberbauer R, Klauser-Braun R: Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 19: 2407-2413, 2008
31. Ando R, Nagaya T, Suzuki S, Takahashi H, Kawai M, Okada A, Yasui T, Kubota Y, Umemoto Y, Tozawa K, Kohri K: Kidney stone formation is positively associated with conventional risk factors for coronary heart disease in Japanese men. J Urol 189: 1340-1346, 2013
32. ARIC Investigators: The Atherosclerosis Risk in Communities (ARIC) study: Design and objectives. Am J Epidemiol 129: 687-702, 1989
33. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
34. Grams ME, Rebholz CM, McMahon B, Whelton S, Ballew SH, Selvin E, Wruck L, Coresh J: Identification of incident CKD stage 3 in research studies. Am J Kidney Dis 64: 214-221, 2014
35. Baecke JAH, Burema J, Frijters JER: A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36: 936-942, 1982
36. Akoudad S, Szklo M, McAdams MA, Fulop T, Anderson CAM, Coresh J, Ko¨ ttgen A: Correlates of kidney stone disease differ by race in a multi-ethnic middle-aged population: The ARIC study. Prev Med 51: 416-420, 2010
37. Johnson RJ, Kivlighn SD, KimYG, Suga S, Fogo AB: Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis 33: 225-234, 1999
38. Saucier NA, Sinha MK, Liang KV, Krambeck AE, Weaver AL, Bergstralh EJ, Li X, Rule AD, Lieske JC: Risk factors for CKD in persons with kidney stones: A case-control study in Olmsted County, Minnesota. Am J Kidney Dis 55: 61-68, 2010
39. Kramer HJ, Choi HK, Atkinson K, Stampfer M, Curhan GC: The association between gout and nephrolithiasis in men: The Health Professionals’ Follow-Up Study. Kidney Int 64: 1022-1026, 2003
40. Roughley MJ, Belcher J, Mallen CD, Roddy E: Gout and risk of chronic kidney disease and nephrolithiasis: Meta-analysis of observational studies. Arthritis Res Ther 17: 90, 2015
41. Gambaro G, Favaro S, D’Angelo A: Risk for renal failure in nephrolithiasis. Am J Kidney Dis 37: 233-243, 2001
42. Kadlec AO, Greco KA, Fridirici ZC, Gerber D, Turk TM: Effect of renal function on urinary mineral excretion and stone composition. Urology 78: 744-747, 2011